Agrupación Estratéxica en Xestión e Produción sustentable de Biorrecursos (BioReDes)
Agrupación estratéxica de I+D+i
![Foto de Agrupación Estratéxica en Xestión e Produción sustentable de Biorrecursos (BioReDes)](/img/noimage.png)
![Foto de Hospital Universitario La Paz](/img/noimage_org.png)
Hospital Universitario La Paz
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario La Paz (54)
2024
-
Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes
Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1796-1802
2023
-
Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions
Journal of Clinical Virology, Vol. 167
-
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
International Journal of Infectious Diseases, Vol. 137, pp. 134-143
-
Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver
Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 3, pp. 128-132
-
Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction
Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 150-162
-
Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe
Clinical Infectious Diseases, Vol. 76, Núm. 9, pp. 1628-1635
-
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019–2021
Journal of Medical Virology, Vol. 95, Núm. 12
2022
-
Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria
Open Forum Infectious Diseases, Vol. 9, Núm. 9
2021
-
Hepatitis C reflex testing in Spain in 2019: A story of success
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 3, pp. 119-126
-
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Nature, Vol. 595, Núm. 7869, pp. 707-712
-
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant
Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414
2020
-
GEHEP 010 study: Prevalence and distribution of hepatitis B virus genotypes in Spain (2000–2016)
Journal of Infection, Vol. 81, Núm. 4, pp. 600-606
-
Hospital admissions in individuals with HTLV-1 infection in Spain
AIDS, Vol. 34, Núm. 7, pp. 1019-1027
-
The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendations
The Journal of antimicrobial chemotherapy, Vol. 75, Núm. 5, pp. 1294-1300
2019
-
Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain
Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 5, pp. 1357-1362
-
Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain
Open Forum Infectious Diseases, Vol. 6, Núm. 2
-
Diagnosis of hepatitis C virus infection in Spain: An opportunity to improve
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 4, pp. 231-238
-
Occult hepatitis B and HIV infection
European Journal of Gastroenterology and Hepatology, Vol. 31, Núm. 11, pp. 1403-1407
-
Role of age and comorbidities in mortality of patients with infective endocarditis
European Journal of Internal Medicine, Vol. 64, pp. 63-71
-
Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice
The Journal of antimicrobial chemotherapy, Vol. 74, Núm. 6, pp. 1693-1700